BONVENTURE invests in LillianCare, a Mannheim-based health-tech startup, to enhance local healthcare solutions amid a growing physician shortage.
Target Information
LillianCare, a health-tech startup based in Mannheim, was founded in 2023 by health experts Linus Drop and Daniel Hefel. The company's innovative approach addresses a critical gap in healthcare services, particularly in rural areas where, according to a Robert Bosch Stiftung study, Germany will face a shortage of 11,000 general practitioners by 2035. LillianCare aims to provide modern, community-based medical care by establishing hybrid practice models that combine interdisciplinary teams with digital solutions, including telemedicine.
Currently, LillianCare has opened five hybrid medical practices in Rheinland-Pfalz and Niedersachsen, regions notably affected by a rising number of retiring general practitioners. The company is committed to mitigating potential healthcare access issues by expanding its operations, with plans to establish an additional 400 practices by 2030. The funding received from this investment round will primarily support the development of these new locations, and beginning in 2026, LillianCare plans to scale its model through licensing agreements with independently operated practices leveraging its established infrastructure.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare sector in Germany is at a pivotal point, especially in light of increasing physician shortages exacerbated by demographic changes. Approximately one-third of practicing doctors in rural areas are nearing retirement, contributing to a
Similar Deals
Springboard Health Angels, Pluton Asset Holding AG, Sintra Ventures, Technologiegründerfonds Sachsen, i&i Bio, HIL-INVENT, Brandenburg Kapital → Captain T Cell
2025
Picus Capital, Alven, Heliad, Rubin Ritter, Lars Langusch, Jens Begemann, Debiopharm, Arve Capital, Christoph Haarburger → StratifAI
2025
BONVENTURE
invested in
LillianCare
in 2025
in a Other VC deal